Late Monday, the FDA approved the use of Merck's (MRK) Sylatron drug to treat skin cancer in...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Late Monday, the FDA approved the use of Merck's (MRK) Sylatron drug to treat skin cancer in patients with node-positive melanoma following the removal of the affected part. (PR)